Bruton's tyrosine kinase (Btk) is essential for normal B lymphocyte development and function. The activity of Btk is partially regulated by transphosphorylation within its kinase domain by Src family kinases at residue Tyr-551 and subsequent autophosphorylation at Tyr-223. Activation correlates with Btk association with cellular membranes. Based on specific loss of function mutations, the Btk pleckstrin homology (PH) domain plays an essential role in this activation process. The Btk PH domain can bind in vitro to several lipid end products of the phosphatidylinositol 3-kinase (PI 3-kinase) family including phosphatidylinositol 3,4,5-trisphosphate. Activation of Btk as monitored by elevation of phosphotyrosine content and a cellular transformation response was dramatically enhanced by coexpressing a weakly activated allele of Src (E378G) and the two subunits of PI 3-kinase-␥. This activation correlates with new sites of phosphorylation on Btk identified by two-dimensional phosphopeptide mapping. Activation of Btk was dependent on the catalytic activity of all three enzymes and an intact Btk PH domain and Src transphosphorylation site. These combined data define Btk as a downstream target of PI 3-kinase-␥ and Src family kinases.Bruton's tyrosine kinase (Btk) is a nonreceptor tyrosine kinase that contains a pleckstrin homology (PH) domain but no apparent lipid modification motif (1). Btk is critical for development and signaling. Btk mutations are associated with the genetic diseases human X-linked agammaglobulinemia (XLA) and murine X-linked immunodeficiency (Xid; refs. 2-5). XLA patients have a dramatic decrease in the number of mature B cells and circulating Ig levels (6). Xid mice or mice with a targeted disruption of Btk have diminished B cell numbers and levels of certain Ig classes (7-9).PH domains are primarily involved in protein-protein or protein-lipid interactions and regulate enzyme function by controlling interacting partners or cellular localization (10,11). The N-terminal PH domain of Btk is essential for its activation and biological activity. A mutation in the Btk PH domain causes Xid (R28C; refs. 4 and 5), and other mutations within the PH domain also result in XLA (12, 13). In contrast, a Glu-to-Lys mutation (E41K, BTK*) in the PH domain activates Btk and increases membrane association (14). These gain or loss of function mutations suggest that the PH domain is a critical regulatory domain for Btk activation but give little information regarding specific signaling mechanisms.The PH domain of Btk was recently shown to bind the phosphatidylinositol 3-kinase (PI 3-kinase) lipid product phosphatidylinositol 3,4,5-trisphosphate [PI(3,4,5)P 3 ] (15, 16) and inositol 3-phosphates in vitro (17). Computer modeling identified several residues within the Btk PH domain including Lys-12, Phe-25, and Arg-28, which are thought to be essential for binding these lipid molecules (15,16,18,19). Interestingly, mutation of these residues results in human XLA (e.g., F25S and R28H; ref. 12) or murine Xid (R28C...